Search results
Genentech withdraws use of Gavreto in US for a type of thyroid cancer, says partner Blueprint
Reuters via Yahoo News· 11 months agoThe U.S. Food and Drug Administration had granted accelerated approval to Gavreto in 2020 for...
Roche's head of pharmaceuticals to leave company
Reuters via Yahoo Finance· 1 year agoZURICH (Reuters) -Roche said on Monday the head of its pharmaceuticals division had decided to leave after 16 years with the Swiss drugmaker, heralding a...
German Merck’s MS drug falls short in pair of Phase 3 tests
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: An emerging class of drugs under development to treat multiple sclerosis suffered...
Roche looking to sell or shut down California biologic drug plant
Reuters via Yahoo Finance· 1 year agoSwiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in...
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
Motley Fool via Yahoo Finance· 6 months agoIn late November, Roche's (OTC: RHHBY) subsidiary Genentech and the chipmaker Nvidia (NASDAQ: NVDA)...
UPDATE 1-Roche looking to sell Vacaville, California plant
Reuters via Yahoo Finance· 1 year agoSwiss drugmaker Roche Holding AG plans to sell or close its drug manufacturing plant in Vacaville, California, or it will shut the factory down by 2029, according to e-mailed letters to the ...
JPM24: Nvidia’s AI dreams, Sarepta’s rosy outlook and Jeff Jonas’ new job
BioPharma Dive via Yahoo Finance· 5 months agoBiotechnology investors and executives appeared eager to dive into this year’s J.P. Morgan...
Bristol Myers looks to new CEO as competition from generic drugs heats up
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bristol Myers Squibb said on Wednesday evening its CEO Giovanni Caforio would step down...
Factbox-Who are OpenAI's new board members?
Reuters via Yahoo News· 3 months ago(Reuters) - Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ouster...
Lonza to buy large biologics site from Roche in US for $1.2 billion
Reuters via Yahoo Finance· 3 months ago(Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it would buy one of the world's...
